Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-06-15 18:42:37
Reporting Period:
Filing Date:
Accepted Time:
2015-06-15 18:42:37
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219023 J W David Mcgirr C/o Relypsa, Inc.
100 Cardinal Way
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-11 1,220 $34.67 3,742 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. Represents shares sold to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") and delivery of shares.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.16 to $35.14, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. Includes 2,250 RSUs.